Cargando…
Advances in the Management of Central Nervous System Metastases from Breast Cancer
Central nervous system (CNS) metastases are common in breast cancer (BC) patients and are particularly relevant as new treatments for BC are prolonging survival. Here, we review advances in the treatment of CNS metastases from BC, including radiotherapy, systemic therapies, and the evolving role of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604332/ https://www.ncbi.nlm.nih.gov/pubmed/36293379 http://dx.doi.org/10.3390/ijms232012525 |
_version_ | 1784817787218165760 |
---|---|
author | Avila, Jorge Leone, José Pablo |
author_facet | Avila, Jorge Leone, José Pablo |
author_sort | Avila, Jorge |
collection | PubMed |
description | Central nervous system (CNS) metastases are common in breast cancer (BC) patients and are particularly relevant as new treatments for BC are prolonging survival. Here, we review advances in the treatment of CNS metastases from BC, including radiotherapy, systemic therapies, and the evolving role of immunotherapy. The use of radiotherapy and chemotherapy is the cornerstone of treatment for CNS metastases. However, new targeted therapies have recently been developed, including anti-HER2 agents and antibody–drug conjugates that have presented promising results for the treatment of these patients. |
format | Online Article Text |
id | pubmed-9604332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96043322022-10-27 Advances in the Management of Central Nervous System Metastases from Breast Cancer Avila, Jorge Leone, José Pablo Int J Mol Sci Review Central nervous system (CNS) metastases are common in breast cancer (BC) patients and are particularly relevant as new treatments for BC are prolonging survival. Here, we review advances in the treatment of CNS metastases from BC, including radiotherapy, systemic therapies, and the evolving role of immunotherapy. The use of radiotherapy and chemotherapy is the cornerstone of treatment for CNS metastases. However, new targeted therapies have recently been developed, including anti-HER2 agents and antibody–drug conjugates that have presented promising results for the treatment of these patients. MDPI 2022-10-19 /pmc/articles/PMC9604332/ /pubmed/36293379 http://dx.doi.org/10.3390/ijms232012525 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Avila, Jorge Leone, José Pablo Advances in the Management of Central Nervous System Metastases from Breast Cancer |
title | Advances in the Management of Central Nervous System Metastases from Breast Cancer |
title_full | Advances in the Management of Central Nervous System Metastases from Breast Cancer |
title_fullStr | Advances in the Management of Central Nervous System Metastases from Breast Cancer |
title_full_unstemmed | Advances in the Management of Central Nervous System Metastases from Breast Cancer |
title_short | Advances in the Management of Central Nervous System Metastases from Breast Cancer |
title_sort | advances in the management of central nervous system metastases from breast cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604332/ https://www.ncbi.nlm.nih.gov/pubmed/36293379 http://dx.doi.org/10.3390/ijms232012525 |
work_keys_str_mv | AT avilajorge advancesinthemanagementofcentralnervoussystemmetastasesfrombreastcancer AT leonejosepablo advancesinthemanagementofcentralnervoussystemmetastasesfrombreastcancer |